These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 22906075

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
    Wang XL, Fang JP, Tang RY, Chen XM.
    BMC Cancer; 2010 Jun 17; 10():299. PubMed ID: 20565772
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
    Eroğlu A, Ersöz C, Karasoy D, Sak S.
    Adv Clin Exp Med; 2017 Jun 17; 26(2):245-249. PubMed ID: 28791841
    [Abstract] [Full Text] [Related]

  • 5. The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer.
    Ding M, Fu X, Tan H, Wang R, Chen Z, Ding S.
    Mol Med Rep; 2012 Nov 17; 6(5):1023-9. PubMed ID: 22923155
    [Abstract] [Full Text] [Related]

  • 6. Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?
    Kandemir NO, Barut F, Bektas S, Ozdamar SO.
    Pathol Oncol Res; 2012 Apr 17; 18(2):253-62. PubMed ID: 21785902
    [Abstract] [Full Text] [Related]

  • 7. Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications.
    Gou HF, Chen XC, Zhu J, Jiang M, Yang Y, Cao D, Hou M.
    J Exp Clin Cancer Res; 2011 Jan 28; 30(1):14. PubMed ID: 21272377
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
    Špirić Z, Eri Ž, Erić M.
    Int J Surg Pathol; 2015 Dec 28; 23(8):629-37. PubMed ID: 25911567
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
    Schoppmann SF, Fenzl A, Schindl M, Bachleitner-Hofmann T, Nagy K, Gnant M, Horvat R, Jakesz R, Birner P.
    Breast Cancer Res Treat; 2006 Sep 28; 99(2):135-41. PubMed ID: 16555123
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma.
    Acs G, Paragh G, Rakosy Z, Laronga C, Zhang PJ.
    Mod Pathol; 2012 Feb 28; 25(2):163-77. PubMed ID: 22020194
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H, Yang Y, Xiao J, Yang S, Liu Y, Kang W, Li X, Zhang F.
    Microvasc Res; 2014 May 28; 93():1-8. PubMed ID: 24603190
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.